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Justificativa e Objetivos: Helicobacter pylori é uma bactéria Gram negativa que coloniza o estômago de apro-
ximadamente 50% da população humana mundial. Este microrganismo é o principal agente causal de gastrite 
e um importante fator de risco para o desenvolvimento deúlcera péptica e carcinoma gástrico. Os fatores que 
determinam essa diversidade de manifestações clínicas permanecem incertos, mas podem estar relacionados 
com a interação dos fatores bacterianos, sistema immune do hospedeiro e variáveis ambientais. O objetivo 
desta revisão é fornecer uma visão geral destes fatores que influenciam na susceptibilidade a desordens se-
veras de infecção por H. pylori. Metodo: Para isso, foram selecionados artigos originais e de revisão através 
da pesquisa nas bases de dados bibliográficos PubMed, Portal de Periódicos CAPES e SCIELO. Resultados: H. 
pylori possui um conjunto de fatores de patogenicidade, tais como cagA, vacA, iceA, babA, para colonizar a 
mucosa gástrica e estabelecer infecção crônica. Estes fatores bacterianos são agentes essenciais em modular 
a resposta imune envolvida na iniciação da carcinogênesegástrica. Os fatores genéticos do hospedeiro contri-
buem para regular a resposta inflamatória e para o agravamento da lesão da mucosa gástrica uma vez que a 
infecção gástrica por H. pylori induz a produção de várias citocinas pró e anti-inflamatórias no hospedeiro. O 
papel prejudicial dos fatores ambientais está relacionado com as precárias condições socioeconômicas, com o 
consumo de sal, com o tabagismo e com o consumo de álcool. Conclusão: Ao decifrar as regras deterministas 
- se houver - dessa interação entre fatores da bactéria, do hospedeiro e variáveis ambientais, será possível 
prever, tratar e, finalmente, prevenir graves doenças gastroduodenais. 
Background and Objectives: Helicobacter pylori is a Gram-negative bacterium that colonizes the stomach of 
approximately 50% of the world´s human population. This microorganismis the major causal agent of gastritis 
and is an important risk factor for the development of peptic ulcer disease and gastric carcinoma. The factors 
that determine these diverse clinical outcomes are subject to continuous investigations and is thought to be 
determined by interaction of bacterial factors, host immune system and environmental variables. The aim of 
this review is to provide an overview of these factors that influence susceptibility to severe outcomes of H. pylori 
infection. Methods: For this, original and review articles were selected by searching the PubMed, CAPES Portal 
Journals and SCIELO bibliographic databases. Results: H. pylori possesses a set of pathogenicity factors, such 
as cagA, vacA, iceA, babA for colonizing the gastric mucosa and establishing a chronic infection. These bacterial 
factors are essential players in modulating the immune responseinvolved in the initiation of the carcinogenesis 
in the stomach. Host genetic factors contribute to the regulation of the inflammatory response and in the 
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HELICOBACTER PYLORI PATHOGENICITY GENES, CYTOKINE POLYMORPHISMS AND ENVIRONMENTAL FACTORS AFFECT THE DEVELOPMENT OF GASTRIC DISEASES: AN OVERVIEW
Júlia Silveira Vianna, Eduardo Almeida da Silva, Ivy Bastos Ramis.
INTRODUCTION
Helicobacter pylori is a micro-aerophilic spi-
ral-shaped flagellar Gram-negative bacterium that col-
onizes the gastric mucosa of approximately 50% of the 
world´s human population.1 The prevalence in developing 
countries is estimated between 60–90%, and in the de-
veloped world is between 25–35%.2
H. pylori induces a chronic gastric inflammation, 
which is asymptomatic in the majority of the patients. 
However, it is estimated that 15 to 20% of H. pylori in-
fected individuals will develop peptic ulcer, and approx-
imately 1% will develop gastric cancer.3 The interaction 
of bacterial pathogenicity factors, host factors and 
environmental and lifestyle factors, determine the sever-
ityof gastric damage and the clinical outcome of H. pylori 
infection (Figure 1).4
The H. pylori genome has a high plasticity, there-
fore, genomic variations of the strains maybe responsible 
for the coding of different pathogenic factors capable of 
determining various types of gastric lesions in the host.5 
It has been described as biomarkers of pathogenicity of 
H. pylori, cagA (cytotoxin-associated gene A), vacA (vacuo-
latingcytotoxin), iceA (induced by contact with epithelium), 
babA (blood-group antigen-binding adhesin A), among 
others genes.6-9
The host’s immune system plays an important role 
in the pathogenesis of gastroduodenal disorders by 
regulating the nature and the intensity of the inflamma-
tory response to infection by H. pylori. Factors such as 
cytokines are involved in the initiation and regulation of 
this response.10 The inflammatory cells that are recruited 
to the gastric mucosa during infection produce several 
pro- and anti-inflammatory cytokines.11 In this sense, it is 
noteworthy that the polymorphism in the genes encod-
ing interleukins (IL) 1β, 1RN, 6, 8 and 10 are associated 
with increased susceptibility to gastric diseases.12-17
The combined presence of environmental factors, 
such as, household crowding, inadequate eating habits, 
low socioeconomic conditions, poor hygienic, excessive 
alcohol consumption and smoking are related with H. 
pylori infection, especially when one takes into account 
aggravation of mucosal damage once the gastric infection with H. pylori induces the mucosal production of 
various pro- and anti-inflammatory cytokines in the host. The harmful role of environmental factors is related 
to poor socioeconomic conditions, salt intake, smoking and alcohol consumption. Conclusion: By deciphering 
the deterministic rules – if any – of this interplay between factors of the bacterium, host and environmental 
variables, we will eventually be able to predict, treat, and ultimately prevent serious gastroduodenal diseases.
Figure 1. A schematic to explain why only certain individuals infected by H. pylori develop more severe gastic diseases. 
The interplay between bacterial, host and evironmental/behavioral factors determine the different clinical outcomes 
of H. pylori - infected patients.
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by the International Cancer Research Agency (IARC).27 H. 
pylori infection promotes gastric carcinogenesis by at le-
ast five different mechanisms: (1) increased endogenous 
DNA damage and decrease repair activities, (2) induction 
of mutations in the mitochondrial DNA, (3) generation of 
a phenotype that induces mutations in the nuclear geno-
me (4) disruption of the balance between cell prolifera-
tion and apoptosis and (5) induction of an intense gastric 
inflammatory response that lasts over decades that 
produces chronic oxidative stress and adaptive changes 
in gastric epithelial and immune cell pathobiology.28
The gastric cancer classification by system Lauren-
classifies gastric adenocarcinoma in intestinal or diffuse.29 
The intestinal-type is more frequently observed in older 
patients and it is linked closely to environmental and 
dietary risk factors. The pathogenesis of the intestinal 
type includes a sequence of events that begins with H. 
pylori-induced superficial gastritis, progressing towards 
chronic atrophic gastritis, intestinal metaplasia, dysplasia 
and finally gastric cancer. In diffuse type the patients ty-
pically are younger associated with host genetic factors 
and is generally less commom, with a worse prognosis 
than those with the intestinal type. The pathogenesis of 
diffuse type is poorly understood, although H. pylori in-
fection is also a predisposing factor.30 Anatomically, gas-
tric adenocarcinomas are classified as proximal (cardia) 
and distal (noncardia). The longstanding inflammatory 
response against H. pylori in the gastric mucosa may 
cause sustained tissue injury leading to the development 
of distal gastric adenocarcinoma.31
Lastly, there are a pathogenic link between H. pylori 
infection and MALT lymphoma, so much that, according 
to the Maastricht III Consensus Report, H. pylori eradication 
is the treatment of first choice for H. pylori infected indi-
viduals with stage I low grade gastric MALT lymphoma.32
Role of bacterial pathogenicity genes in the gastric 
disorders
Determination of pathogenicity genes may provide 
information regarding to the prognosis of infection by 
H. pylori.33 The first gene of pathogenicity identified 
in H. pylori was cagA. This gene is highly prevalent in 
strains from different geographic areas.6,34 The cagA gene 
is located at one end of a 40-kb DNA insertion called 
cag pathogenicity island (cagPAI). This gene is secreted 
through the type IV secretion system (T4SS) and then-
transported to host cells.35 Once inside gastric epithelial 
cells, the CagA undergoes tyrosine phosphorylation in 
its repeat region of five amino acids Glu-Pro-Ile-Tyr-Ala 
(EPIYA). This phosphorylation is mediated by Src kinase, 
a cytoplasmic protein tyrosine kinase. CagA tyrosine 
phosphorylated subsequently binds to Src homology 2 
(SH2) domain, that contain host cell proteins, such as, the 
tyrosine phosphatase SHP-2, the C-terminal Src kinase 
(CSK) and the adapter protein Crk. This results in cytoske-
letal reorganization and cell elongation-a phenotype 
that leads to the dispersion of cells and morphological 
changes for “hummingbird phenotype”.36 The cagA-SHP-2 
interaction constitutes the biological basis of cagA as 
their main routes oftransmission, oral–oral and fe-
cal–oral. Besides, factors as smoking, eating habits and 
alcohol consumption have been associated with a higher 
risk of the development of peptic ulcer and gastric cancer 
in people infected by H. pylori.18-20
The aim of this review is to provide an overview of 
bacterial, environmental, and host factors that influence 
susceptibility to severe outcomes of H. pylori infection. 
METHODS
Original and review articles were selected by se-
arching the PubMed (Literature of International Health 
Sciences), CAPES Portal Journals and SCIELO bibliogra-
phic databases. The selection of the articles was based 
on two criteria: 1) published between the years 1993 
and 2015; 2) articles whose authors contributed with 
important insights into the issues, regardless of the ye-
ar of publication. The following descriptors were used: 
Helicobacter pylori, pathogenicity genes, host genetic 
polymorphism, cytokine polymorphism, environmental 
variables, gastroduodenal diseases and epidemiology.
RESULTS AND DISCUSSION
Helicobacter pylori infection: From gastric inflamma-
tion to gastric carcinogenesis
The clinical manifestations of H. pylori infection can 
be chronic gastritis; peptic ulcer; adenocarcinoma; and 
gastric lymphoma mucosa- associated lymphoid tissue 
(MALT).21,22 Firstly, the infection of the stomach by H. pylo-
ri induces inflammation of the gastric mucosa (gastritis) 
and is estimated that occur in the most patients infected 
by H. pylori.23 H. pylori infection may be associated with 
decreased or increased gastric acid secretion, depending 
on the distribuition and severity of gastritis.4
The interplay of gastritis and acid secretion are key 
determinants in disease outcomes such as peptic ulcer 
and/or gastric cancer.23 Ulceration corresponds to the 
loss of mucosal integrity as the result of disequilibrium 
between defensive mucosa-protective factors (mucus 
bicarbonate layer and phospholipid surfactant layer) and 
aggressive injurious factors (strong acid and high prote-
olytic activity in gastric secretions). When ulcers develop 
in the acid-peptic environment of the gastroduodenum, 
they are called peptic ulcer disease.24 The development 
of  duodenal ulcers is associated with gastritis and with 
increased gastric acid production, where as the deve-
lopment of gastric ulcers is related with gastritis and 
with gastric reduced acid production, conditions that 
predispose also the developing of gastric atrophy (loss 
of gastric glands), intestinal metaplasia (the replacement 
of glandular and/or foveolar epithelium by intestinal 
epithelium), and finally gastric cancer.25,26
In relation to gastric cancer, although its etiology is 
multifactorial, H. pylori is the main cause of gastric carci-
nogenesis and was categorized in 1994 as a carcinogen I 
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and i1 genotypes, and that the s and i regions were the 
key determinants of vacuolating cytotoxin activity.47 
Another study found that strains which carried the vacA 
s1/m1 gene showed significant associations with severe 
chronic gastritis.48 The iceAgene has two alleles: iceA1 
and iceA2. The expression of iceA1 is regulated by the 
contact of H. pylori with gastric epithelial cells and is 
associated with peptic ulcer and gastric cancer, whereas 
expression of iceA2 is related to asymptomatic gastritis.8 
A study in southern Brazil showed that the iceA1 allele 
was related to erosive gastritis, whereas the iceA2 allele 
was associated with enanthematous gastritis.49 The babA 
gene encodes a membrane protein, named BabA adhe-
sin, which binds to the Lewis b blood group antigens in 
gastric cells. The babA gene is a factor of adhesion, one of 
the characteristics of H. pylori that assists in establishing 
persistent colonization of the gastric epithelium and con-
tributes to its pathogenicity, by to allow intimate contact 
between bacterium and epithelium, and facilitate the 
release of factors pathogenicity. Although three alleles 
of the babgene have been identified (babA1, babA2 and 
babB), only the babA2 gene product is able to bind to 
Lewis b antigen.50A recent study showed that the babA2 
gene correlated positively with bacterial density score, 
activity of inflammation and chronic inflammation of 
gastric mucosa.51
Influence of cytokines genes polymorphisms in the 
gastric diseases
H. pylori induces gastric lesions that start by chronic 
inflammation in the gastric mucosa that is mediated by 
an array of pro- and anti-inflammatory cytokines.52 Ge-
netic polymorphisms in genes that codify proinflamatory 
cytokines such as IL-1β, IL-6 and IL-8; and anti-inflamma-
tory cytokines like IL-1RNand IL-10, directly influence in-
ter-individual variation in the magnitude of the cytokine 
response, and this clearly contributes to an individual’s 
ultimate clinical outcome.53 In general, in the H. pylori 
infection, the gastric inflammation is increased and the 
acid inhibition is potente in patients with high producer 
alleles of pro-inflammatory cytokines and low producer 
alleles of anti-inflammatory cytokines, which results in 
a higher risk for the development of atrophic gastritis, 
gastric ulcer or gastric cancer. On the other hand, low 
producer allele carriers of pro-inflammatory cytokines 
and high producer allele carriers of anti-inflammatory 
cytokines have decreased inflammation and weak acid 
inhibition, resulting in a mild gastric inflammation.54
The family of the IL-1 gene contains the genes IL-1A, 
IL-1B and IL-1RN.55 IL-1B encodes IL-1β, a pro-inflamma-
tory cytokine and a powerful inhibitor of gastric acid 
secretion, which plays an important role for initiating 
and amplifying the inflammatory response to H. pylori 
infection.56 There are three single nucleotide polymor-
phisms (SNPs) in the IL-1β gene: a T-C base transition 
at position -31 and C-T base transitions at positions 
-511 and +3954 from the transcriptional start site.57 The 
presence of the T allele at positions -511 and +3954; and 
of C allele at position -31 is associated with high levels 
a pathogenicity factor, due to induction of abnormal 
proliferation and movement of gastric epithelial cells, 
changes that may eventually lead to gastric atrophy and 
gastric cancer.37
The CagA protein of H. pylori acts as a highly immu-
nogenic antigen. The structure of the cagA gene reveals 
a 5’ highly conserved region and a 3’ region containing 
a variable number of repeat sequences, which leads to 
variation in the length of the protein and can result in 
diverse host responses, including different degrees of 
inflammatory response.5 These variations in the repeat 
region of cagAEPIYA have also been associated with pa-
thogenicity of H. pylori. Four distinct types of EPIYA have 
been identified and classified as, EPIYA-A, -B, -C and -D. 
CSK specifically binds to the tyrosine-phosphorylated 
EPIYA-A or -B, whereas SHP-2 specifically binds to the 
tyrosine-phosphorylated EPIYA-C or –D.36cagA strains 
of H. pylori found in the western world typically contain 
EPIYA-A, -B and -C in the EPIYA repetition region in 
the C-terminal. In contrast, the cagA strains of the East 
Asian have EPIYA-A, -B and a specific sequence Asian 
CagAEPIYA-D.38 The number of segments EPIYA-C in 
H. pylori strains from western countries have shown to 
influence the degree of pathogenicity as well as the 
oncogenic potential, and may serve as a marker for 
identifying high-risk populations.39 This occurs because 
the presence of EPIYA-C segments of the CagA protein 
appears to significantly contribute to the transcriptional 
activation of IL-8, through activation of NF-kB (factor 
nuclear kappa B).40 IL-8 plays a crucial role by chemo at-
tracting and activating neutrophils to the site of infected 
gastric mucosa.41 Batista et al. showed that increasing of 
the number of segments EPIYA-C was associated with 
precancerous gastric lesions and with decreased serum 
levels of pepsinogen I, which reflects the functional and 
morphological status of the gastric mucosa.42Also, it was 
observed that infection by cagA-positive H. pylori strains 
harboring multiple EPIYA-C repeats is associated with the 
presence of peptic ulcer.43
Another important disease-associated pathogeni-
city genes of H. pylori are vacA, iceA and babA.7-9 The vacA 
gene encodes a vacuolating cytotoxin (VacA), which can 
damage the gastric epithelial cells due to induce the 
formation of cytoplasmic vacuoles.44 The gene consists 
of three variable regions: the signal region (s- encoding 
the signal peptide), with two alleles, s1 (subtypes s1a, s1b, 
s1c) and s2; the medium region (m), with the alleles m1 
and m2; and the intermediate region (i), containing the 
alleles i1 and i2.44,45 The combination of alleles of the s, 
m and I regions determines the vacuolating cytotoxin 
production and is associated with the pathogenicity of 
the bacterium. In general, the strains containing s1/m1/i1 
alleles produce large amounts of vacuolating cytotoxin, 
reason where by this genotype seems to be associated 
with more severe pathologies, as peptic ulcer and gastric 
cancer. In contrast, strains of type s1/m2 and s2/m2/
i2 have moderate and none cytotoxic activity, respec-
tively.7,46 A recent study showed that the best markers 
of gastric cancer and duodenal ulcer were the vacA s1 
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IL-10 is a pleiotropic anti-inflammatory cytokine 
produced by activated immune cells.73 It is capable of 
inhibiting the production of pro-inflammatory cytokines 
like IFN-γ, IL-1, IL-2, IL-3, IL-6, IL-8, TNF-α, and GM-CSF 
and inducing B-cell proliferation and differentiation.74,75 
A C-T base transition located at positions -819, and C-A 
base transition at position -592 have been identified in 
the 5´ flanking region of the IL-10 gene. These SNPs are 
related to different serum level of IL-10 in vivo.75,76 The C 
allele at positions -819 and -592 has been associated with 
high IL-10 production and the T allele at position -819 and 
the A allele at position -592 has been related with low 
production.77 The low IL-10 production in patients infect-
ed with H. pylori results in increased gastric inflammation 
intensity, hypochlorhydria and increased risk of gastric 
atrophia and gastric cancer.74
Relationship of environmental factors with the H. 
pylori infection
The knowledge of the epidemiology and mode 
of transmission of H. pylori is important to prevent its 
spread, since this bacterium is present in nearly half the 
world’s population. Such knowledge may be useful in 
identifying high-risk populations, especially in areas with 
higher rates of peptic ulcer and gastric cancer.5,78,79
The transmission of H. pylori occursfrom person 
to person by oral–oral (through saliva, dental plaque, 
backflow of gastric contents) or fecal–oral (through wa-
ter contaminated) routes.78 Yu et al. (2015) showed that 
dental plaque is risk factor of oral H. pylori infection.80 
In Brazil, studies showed that mothers infected with H. 
pylori represent a greater risk factor to infected their 
children; and that breastfeeding does not protect against 
acquisition of H. pylori, conversely, an infected mother 
can transmit of the disease to the child. 81,82
The theory that the major risk factors for infection 
are poor socioeconomic and hygienic conditions begin-
ning in childhood was supports by Chen et al. (2014).83 
Childhood infections, such as, tonsillitis, diarrhea and 
diphtheria, are associated with decreased secretion of 
gastric acid, as well as with malnutrition. Regions where 
childhood infections and malnutrition are common pro-
vide the ideal environment for H. pylori colonization.84
There is a strong correlation between poor socio-
economic conditions and H. pylori infection. In general, 
inadequate sanitation practices, low family income, poor 
hygiene and household crowding may be related to a 
higher prevalence of this infection.19 The transmission of 
H. pylori occurs from infected mothers to their offspring 
and among siblings.85 A study, with Brazilian children, 
showed that the number of siblings and nursery atten-
dance were positively associated with H. pylori infection 
and also that the house location (served by paved road 
or not) is a potential risk factor for infection, indicating 
that contaminated soil may be a source of infection, and 
concluding that the H. pylori infection in children is hi-
ghly related to poor hygiene and crowded conditions.86A 
study conducted in six Latin-American countries also 
reported that crowding was positively associated with H. 
of IL-1 secretion.25 It has been shown that IL-1β-31, IL-
1β-511 and  IL-1β+3954 polymorphisms are related with 
hypochlorhydria, chronic atrophic gastritis, gastric ulcer 
and gastric cancer in response to H. pylori infection.52,58 
The IL-1RN encodes the IL-1 receptor antagonist (IL-1ra), 
an anti-inflammatory cytokine that competitively binds 
to IL-1 receptors and thereby modulates the potentially 
damaging effects of IL-1.12 IL-1RN play a decisive role in 
modulating the risk of developing hypochlorhydria, gas-
tric atrophy and gastric cancer in the presence of H. pylori 
infection.59 IL-1RN gene contains an 86-bp variable num-
ber of tandem repeats polymorphism (VNTR) in intron 2, 
which leads to the presence of 5 different alleles: allele 1 
(4 repeats), allele 2 (2 repeats), allele 3 (5 repeats), allele 
4 (3 repeats), and allele 5 (6 repeats).60 The 4-repeats 
(IL-1RN*1) and 2-repeats (IL-1RN*2) alleles are the most 
common, whereas the others account for less than 5%.61 
The allele 2 (IL-1RN*2) is associated with enhanced IL-1β 
production.62 Studies in different populations revealed 
association between individual’s carriers of the allele 2 
and increased risk of developing chronic gastritis, gastric 
ulcer and gastric cancer.63,64
IL-6 is a pro-inflammatory cytokine that acts as an 
inflammatory mediator and endocrine regulator, playing 
an important role in host defense mechanisms as a mes-
senger between innate and adaptive systems.65Moreover, 
it is involved in the regulation of various cellular functions, 
such as, proliferation, apoptosis and angiogenesis.66A 
nucleotide change from G to C at position -174 in the 
promoter region of the IL-6 genewas described. This SNP 
may result in inter-individual variation in transcription 
and expression of the IL-6; and therefore influence an 
individual’s susceptibility to a diverse range of diseases. 
MucosalIL-6 levels are elevated in H. pylori-associated 
gastritis and diminished after eradication of the infec-
tion.55 In 2012, Liu et al. showed an increased cancer risk 
for individuals with the CC genotype compared to those 
carrying the GG genotype in African populations.67
The pro-inflammatory factor IL-8is recognized as 
a neutrophil and lymphocyte chemotactic factor and 
inductor of cell proliferation, migration and angiogene-
sis.54,68 Gastric mucosal levels of IL-8 increase significantly 
after H. pylori infection and parallel to the severity of 
gastritis.69 The IL-8 genecontains a SNP (T-A base tran-
sition) at position -251, in the proximal promoter region. 
The IL-8-251A allele affects IL-8 gene transcription and 
tended to be associated with increased IL-8 production 
by gastric cells and with more severe inflammation.53 
In recent years, a number of studies examining the IL-8 
-251T/A SNP showed varying results.Recent meta-anal-
yses suggest that IL-8 -251T/A SNP is associated with 
increased peptic ulcer and gastric cancer risks among 
Asians.70 However, a study examining European patients 
did not find the correlation between the IL-8-251T/A SNP 
and gastric cancer.71 Moreover, a Brazilian study found 
that individuals with A/A genotype may have protective 
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ated transmission of H. pylori (same or different strain) 
between the individuals who live in the same household, 
due to a greater opportunity of personal contact.19
In addition to the factors described above, other 
variables, such as smoking, alcohol consumption and 
diet may influence the infection by H. pylori. The smoking 
can be involved in the transmission of infection due the 
handling and sharing of cigarettes among smokers.87 A 
population-based prospective study with Japanese men 
suggested that cigarette smoking and H. pylori infection 
are significant risk factors for gastric cancer.88 The strong 
oxidising effect of cigarette smoke is able to dramatically 
induce oxidative DNA damage.4
Regarding alcohol consumption, Sánchez-cuen et al 
(2014) found that the risk of infection by H. pylori is 1.45 
times higher in people who consume alcohol who do not 
consume it.18 It is postulated that alcohol consumption 
facilitates H. pylori infection presumably by damaging 
the gastric mucosa and/or promoting H. pylori adherence 
to gastric mucosa.68
Another factor that influences the infection by H. 
pylori is the diet that may provide noxious agents that 
contribute to H. pylori pathogenicity. The high salt con-
centration in the stomach destroys the mucosal barrier, 
favors colonization by H. pylori, and leads to inflamma-
tion and damage-causing gastritis and diffuse erosion.4 
Inadequate dietary habits are associated with intense 
neutrophilia, higher degree of inflammation and with the 
development of gastric cancer.20
Lastly, a recent study demonstrated a statistically 
significant increase in H. pylori infection among betel 
chewers compared to those who did not chew betel. This 
observation supports the hypothesis that betel chewing 
may affect periodontal health and thus predispose indi-
viduals to colonization with H. pylori.83
CONCLUSION
There are evidences that genes of bacterial patho-
genicity, such as, cagA, vacA s1/m1/i1, iceA1, babA2; host 
genetic polymorphisms, such as, IL-1RN *2, IL-1β (-31C) 
(-511T) (+3954T),IL-8 (-251A), IL-10 (-592A) (-819T); and 
environmental factors as smoke, alcohol consumption 
and diet play a major role in inducing severe gastric 
disorders. Future research must focus on developing a 
diagnostic tool for detect H. pylori and also bacterial and 
host genes associated with a higher severity of gastric 
disease. The identification of patients infected with H. 
pylori that present a high risk of develop peptic ulcer or 
gastric cancer may to determine the most appropriate 
therapeutic intervention and the better treatment.
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